SUBSCRIBE & WIN! Sign up for the Daily CHAT News Today Newsletter for a chance to win a $75 South Country Co-op gift card!

The latest news on COVID-19 developments in Canada for Thursday, March 11, 2021

Mar 11, 2021 | 9:17 AM

The latest news on COVID-19 developments in Canada (all times Eastern):

10:35 a.m.

Bloc Quebecois Leader Yves-Francois Blanchet is using a white rose in the House of Commons to remember those who have died from COVID-19 over the past year.

Blanchet is also calling for Canada to address the inequality and shortcomings in the national health-care system that were exposed during the pandemic.

He is also marking the sacrifices of health-care and other front-line workers, many of whom are women.

10:20 a.m.

Federal Conservative Leader Erin O’Toole is using an address in the House of Commons marking the one-year anniversary of the start of the COVID-19 pandemic by listing the many ways in which Canadians have suffered over the past year.

He’s also criticizing the Liberal government for what he describes as the slow pace of vaccinations to date.

O’Toole says many Canadians have lost their jobs over the past year, while many others are struggling with mental-health challenges, domestic violence and opioid addictions.

The Conservative leader says most Canadians remain unsure when they will get vaccinated, and Canada must learn from the past 12 months and ensure the country is not caught by surprise again in the future.

10:10 a.m.

Prime Minister Justin Trudeau is marking the one-year anniversary of the World Health Organization declaring COVID-19 a pandemic by remembering the more than 20,000 people who have died from the illness.

Speaking in the House of Commons, Trudeau also praised the health-care workers, military personnel and others who have stepped up over the last year to help Canadians through the pandemic.

The prime minister describes the past 12 months as “a tough year, a heartbreaking year, but it is a year we have faced together.”

10 a.m.

U.S.-based vaccine maker Moderna says it has now started giving doses of a B.1.351 COVID-19 variant booster shot to 60 people who have already been vaccinated with the company’s original shot. 

The phase two trial is testing various combinations, including two different sizes of doses of just the booster shot that has adjusted the original vaccine to account for the changes seen in the variant first identified in South Africa.

A third version combines both the original vaccine and the booster shot, attempting to see if one jab can cover the original virus and the new variant.

Lab tests showed Moderna’s original vaccine did produce antibodies when put up against multiple variants of the SARS-CoV-2 virus that causes COVID-19, but the level of response against B.1.351 was as much as six times less than that against the original virus.

This report by The Canadian Press was first published March 11, 2021.

The Canadian Press